3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
34
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Leukemia
11
Prostatic Neoplasms
10
Lymphoma
9
Leukemia, Monocytic, Acute
8
Leukemia, Erythroblastic, Acute
8
Leukemia, Myelomonocytic, Acute
7
Congenital Abnormalities
7
Lymphoma, Follicular
6
Leukemia, Megakaryoblastic, Acute
6
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Leukemia, Biphenotypic, Acute
5
Recurrence
3
Sarcoma, Myeloid
2
Neoplasms
2
Myeloproliferative Disorders
2
Lymphoma, Mantle-Cell
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Eosinophilic, Acute
2
Leukemia, Basophilic, Acute
2
Waldenstrom Macroglobulinemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Pain
1
Myeloid Malignancies
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, T-Cell
1
Interventions
Valganciclovir
3
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
Biopsy
3
Bevacizumab
3
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
2
Nivolumab
2
tocilizumab
1
pomalidomide
1
pembrolizumab
1
liposomal doxorubicin
1
emvododstat
1
efineptakin alfa
1
cabozantinib
1
Zidovudine
1
Sunitinib
1
Polymerase Chain Reaction
1
Nelfinavir
1
Maraviroc
1
Lenalidomide
1
Ipilimumab
1
Immunohistochemistry
1
Imatinib Mesylate
1
HhAntag691
1
Gene Expression Profiling
1
Etoposide
1
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
1
CTLA-4 Antigen
1
Antiretroviral Therapy, Highly Active
1
2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Kaposi
×
Mitoxantrone
×
Clear all
No trials found.